Lind Global Fund II LP 13D/13G Filings for Bone Biologics Corporation (BBLG)

Lind Global Fund II LP 13D and 13G filings for Bone Biologics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
7:19 pm
Unchanged
2024-09-30 13G Bone Biologics Corporation
BBLG
Lind Global Fund II LP 34,180
1.900%
0
(Unchanged)
Filing
2024-02-13
8:03 pm
Purchase
2023-12-31 13G Bone Biologics Corporation
BBLG
Lind Global Fund II LP 34,180
6.000%
34,180increase
(New Position)
Filing